早期宫颈癌腹腔镜根治性子宫切除术后复发的预测因素:一项多机构研究
这项回顾性多机构研究分析了2006年1月至2017年12月间因FIGO 2009分期IA1(伴淋巴血管间隙浸润)、IA2和IB1(≤4 cm)宫颈癌接受腹腔镜根治性子宫切除术的428例连续患者数据,中位随访56个月(范围1-162),54例(12.6%)复发。多变量分析显示肿瘤大小(OR 1.04,95%CI 1.01-1.09,P=0.02)和最终病理存在宫颈残留肿瘤(OR 5.29,95%CI 1.34-20.76,P=0.02)为复发预测因素,而术前锥切降低风险(OR 0.32,95%CI 0.11-0.90,P=0.03)。
要点
- 肿瘤大小和最终病理宫颈残留肿瘤是腹腔镜根治性子宫切除术后复发的独立预测因素。
- 术前锥切与复发风险降低相关(OR 0.32,95%CI 0.11-0.90,P=0.03)。
- 术前锥切和手术时宫颈残留肿瘤与无病生存独立相关,但与疾病特异性生存无关。
核心结论
- 在早期宫颈癌女性中,手术时存在高体积疾病是腹腔镜根治性子宫切除术后复发的独立预测因素;术前锥切和手术时无残留疾病可能起保护作用。
研究设计与样本
- 回顾性多机构研究,纳入2006年1月至2017年12月间因FIGO 2009分期IA1(伴淋巴血管间隙浸润)、IA2和IB1(≤4 cm)宫颈癌接受腹腔镜根治性子宫切除术的连续患者,共428例;采用多变量模型估计调整OR和95%CI,并探索无病生存和疾病特异性生存的影响因素。
主要发现
- 中位随访56个月(范围1-162),54例(12.6%)复发。
- 多变量分析中,肿瘤大小(OR 1.04,95%CI 1.01-1.09,P=0.02)和最终病理存在宫颈残留肿瘤(OR 5.29,95%CI 1.34-20.76,P=0.02)为复发预测因素;术前锥切降低风险(OR 0.32,95%CI 0.11-0.90,P=0.03)。
- 在IB1亚组中,这些预测因素仍显著:肿瘤大小OR 1.05(95%CI 1.01-1.09,P=0.01);最终病理残留肿瘤OR 6.26(95%CI 1.58-24.83,P=0.01);术前锥切OR 0.33(95%CI 0.12-0.95,P=0.04)。
- 术前锥切(HR 0.29,95%CI 0.13-0.91,P=0.03)和手术时宫颈存在残留肿瘤(HR 8.89,95%CI 1.39-17.23,P=0.01)与无病生存独立相关;未发现与疾病特异性生存独立相关的因素。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
OBJECTIVE: To assess predictors of recurrence following laparoscopic radical hysterectomy (LRH) for apparent early stage cervical cancer (CC). METHODS: This is a retrospective multi-institutional study reviewing data of consecutive patients who underwent LRH for FIGO 2009 stage IA1 (with lymphovascular space invasion (LVSI)), IA2 and IB1(≤4 cm) CC, between January 2006 and December 2017. The following histotypes were included: squamous, adenosquamous, and adenocarcinoma. Multivariable models were used to estimate adjusted odds ratio (OR) and corresponding 95% CI. Factors influencing disease-free survival (DFS) and disease-specific survival (DSS) were also explored. RESULTS: 428 patients were included in the analysis. With a median follow-up of 56 months (1-162) 54 patients recurred (12.6%). At multivariable analysis, tumor size (OR:1.04, 95%CI:1.01-1.09, p = .02), and presence of cervical residual tumor at final pathology (OR: 5.29, 95%CI:1.34-20.76, p = .02) were found as predictors of recurrence; conversely preoperative conization reduced the risk (OR:0.32, 95%CI:0.11-0.90, p = .03). These predictors remained significant also in the IB1 subgroup: tumor size: OR:1.05, 95%CI:1.01-1.09, p = .01; residual tumor at final pathology: OR: 6.26, 95%CI:1.58-24.83, p = .01; preoperative conization: OR:0.33, 95%CI:0.12-0.95, p = .04. Preoperative conization (HR: 0.29, 95%CI: 0.13-0.91; p = .03) and the presence of residual tumor on the cervix at the time of surgery (HR: 8.89; 95%CI: 1.39-17.23; p = .01) independently correlated with DFS. No independent factors were associated with DSS. CONCLUSIONS: In women with early stage CC the presence of high-volume disease at time of surgery represent an independent predictor of recurrence after LRH. Conversely, preoperative conization and the absence of residual disease at the time of surgery might play a protective role.
引用
- Casarin J, Buda A, Bogani G, et al. Predictors of recurrence following laparoscopic radical hysterectomy for early-stage cervical cancer: A multi-institutional study. Gynecol Oncol. 2020. PMID: 32665147. doi:10.1016/j.ygyno.2020.06.508
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。